83_FR_54804 83 FR 54594 - Sesame as an Allergen in Foods

83 FR 54594 - Sesame as an Allergen in Foods

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 83, Issue 210 (October 30, 2018)

Page Range54594-54596
FR Document2018-23635

The Food and Drug Administration (FDA or we) invites data and other information on the prevalence and severity of sesame allergies in the United States and the prevalence of sesame-containing foods sold in the United States that are not required to disclose sesame as an ingredient. We are taking this action to inform possible regulatory action on sesame to protect and promote the public health.

Federal Register, Volume 83 Issue 210 (Tuesday, October 30, 2018)
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Pages 54594-54596]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23635]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-3809]


Sesame as an Allergen in Foods

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) invites data and 
other information on the prevalence and severity of sesame allergies in 
the United States and the prevalence of sesame-containing foods sold in 
the United States that are not required to disclose sesame as an 
ingredient. We are taking this action to inform possible regulatory 
action on sesame to protect and promote the public health.

DATES: Submit either electronic or written comments on this document by 
December 31, 2018.

ADDRESSES: You may submit comments as follows. Electronic comments must 
be submitted on or before December 31, 2018. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of December 31, 2018. Comments 
received by mail/hand delivery/courier (for written/paper submissions) 
will be considered timely if they are postmarked or the delivery 
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the

[[Page 54595]]

manner detailed (see ``Written/Paper Submissions'' and 
``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2018-N-3809 for ``Sesame as an Allergen in Foods.''
    Received comments, those filed in a timely manner (see ADDRESSES), 
will be placed in the docket and, except for those submitted as 
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. 
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review 
this copy, including the claimed confidential information, in our 
consideration of comments. The second copy, which will have the claimed 
confidential information redacted/blacked out, will be available for 
public viewing and posted on https://www.regulations.gov. Submit both 
copies to the Dockets Management Staff. If you do not wish your name 
and contact information to be made publicly available, you can provide 
this information on the cover sheet and not in the body of your 
comments and you must identify this information as ``confidential.'' 
Any information marked as ``confidential'' will not be disclosed except 
in accordance with 21 CFR 10.20 and other applicable disclosure law. 
For more information about FDA's posting of comments to public dockets, 
see 80 FR 56469, September 18, 2015, or access the information at: 
https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Carol D'Lima, Office of Nutrition and 
Food Labeling, Center for Food Safety and Applied Nutrition, Food and 
Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-
2033.

SUPPLEMENTARY INFORMATION: 

I. Background

    Food allergies occur when the body's immune system reacts to 
certain food proteins (Ref. 1). Allergic reactions to food due to 
immunoglobulin E (IgE) antibodies cause the body to release 
inflammatory chemicals and can be particularly severe, leading to 
symptoms such as hives, facial swelling, vomiting, wheezing, shock, and 
even death. Because there is no cure for food allergies, allergic 
consumers must use avoidance to prevent allergic reactions. Successful 
avoidance requires, among other things, that allergic consumers and 
their caregivers can read and understand the relevant information on 
packaged food labels and can identify food allergens in other settings, 
such as at retail or food service establishments.
    The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that a 
food (other than a raw agricultural commodity) that bears or contains a 
``major food allergen'' declare the allergen using its ``common or 
usual name.'' A food is misbranded if it contains a major food allergen 
and fails to declare that major food allergen on its label using the 
major food allergen's common or usual name (section 403(w) of the FD&C 
Act). The FD&C Act defines a ``major food allergen,'' in part, as any 
of the following:
     Milk,
     Eggs,
     Fish (e.g., bass, flounder, or cod),
     Crustacean shellfish (e.g., crab, lobster, or shrimp),
     Tree nuts (e.g., almonds, pecans, or walnuts),
     Wheat,
     Peanuts, and
     Soybeans.
    See section 201(qq)(1) of the FD&C Act (21 U.S.C. 321(qq)(1)). When 
Congress amended the FD&C Act regarding food allergens in 2004, these 
eight foods and food groups, out of more than 160 identified food 
allergens, accounted for 90 percent of serious food allergic reactions. 
We issued guidance in 2006 to help the public understand our 
implementation of the amendments, including what foods and 
manufacturers are subject to the amendments and labeling requirements 
(Ref. 2). We issued another guidance in 2014 to clarify the information 
we need when considering whether to exempt certain ingredients derived 
from major food allergens from the allergen labeling requirements (Ref. 
3). These statutory requirements with respect to a label or labeling 
for major food allergens do not alter the authority of the Secretary of 
Health and Human Services under the FD&C Act to require a label or 
labeling for other food allergens (21 U.S.C. 343 note).
    A common or usual name must accurately identify or describe, in as 
simple and direct terms as possible, the basic nature of the food or 
its characterizing properties or ingredients and can either be the name 
established by common use or the name required by a regulation (21 CFR 
102.5). In addition to the specific requirement for allergen labeling, 
any food is misbranded unless its label uses: (1) The common or usual 
name of the food, if it has one, and (2) the common or usual name of 
each ingredient, if the food is made from two or more ingredients 
(section 403(i) of the FD&C Act). Thus, the FD&C Act includes other 
authorities that assist consumers with a food allergy or other reason 
for avoiding an ingredient. For example, the label of a food made with 
sugar must declare this ingredient by its common or usual name--
``sugar''--rather than the chemical name ``sucrose'' (see section 
403(i) of the FD&C Act (21 U.S.C. 343(i))).
    In addition, section 403(x) of the FD&C Act gives us the authority 
to issue regulations requiring the disclosure of spices, flavorings, 
colorings, and incidental additives that are, or contain, allergens 
other than the eight major food allergens. We relied on this authority, 
in part, to require the labeling of carmine and cochineal in foods (see 
74 FR 207).
    In 2014, the Center for Science in the Public Interest, several 
medical professionals, and two consumer advocacy groups submitted a 
citizen petition (Ref. 4) requesting, in part, that we issue a rule to 
require that sesame seeds and sesame products be regulated in a manner 
similar to the manner in which major food allergens are regulated under 
the FD&C Act, and specifically to require sesame's disclosure by the 
common or usual name ``sesame'' in food labeling. The petition noted, 
among other things, that the European Union, Canada, Australia, and New 
Zealand require labeling of

[[Page 54596]]

sesame and provided scientific information to support the petitioners' 
argument that sesame is an allergen of public health concern. The 
petition also requested that we add sesame to our list of allergens in 
our Compliance Policy Guide, which includes discussion of adulteration 
due to insufficient controls to prevent potential allergen cross-
contact (the unintentional incorporation of allergens into foods that 
are not intended to include those allergens) (Ref. 5). Since the 
citizen petition was posted, more than 750 comments have been submitted 
to the docket.
    We are interested in learning more about the prevalence and 
severity of sesame allergies in the United States, and the prevalence 
of sesame-containing foods sold in the United States that are not 
required to disclose sesame as an ingredient. We will consider the data 
and other information submitted, along with previously submitted 
information, to inform possible steps on sesame as an allergen in food 
to protect and promote the public health.

II. Additional Issues for Consideration; Request for Data and 
Information

    We invite comment, particularly scientific data and other evidence, 
about the following topics:

A. Prevalence of Allergies and Allergic Reactions Due to Sesame in the 
United States

    1. What is the prevalence of IgE-mediated sesame food allergies in 
the United States? Please provide any studies or data that support your 
conclusion, and provide your unit of measure (e.g., ``1 in 10,000 
adults''). What is the nature of the allergic response(s) to sesame in 
food and what are the impacts on consumers?
    2. How does the prevalence of IgE-mediated sesame food allergies in 
the United States compare to the prevalence of IgE-mediated allergies 
to the major food allergens? Please provide any studies or data that 
support your conclusion.
    3. What proportion of allergic reactions in the United States may 
be attributed specifically to exposure to undeclared sesame? Please 
provide any studies or data that support your conclusion.
    4. What proportion of allergic reactions to undeclared sesame occur 
in response to sesame found in packaged food products versus sesame 
found in foods served at retail or food service establishments (e.g., 
restaurants, grocery stores, supermarkets, hospitals, nursing homes, 
childcare centers, and temporary food establishments)?
    5. In packaged food products, what proportion of allergic reactions 
to sesame is due to:
    a. Sesame in generically listed spices, flavorings, colorings, or 
incidental additives;
    b. Sesame used as an ingredient and listed by some other name 
(e.g., ``tahini'' rather than ``sesame''); or
    c. Cross-contact?

B. Prevalence and Amounts of Undeclared Sesame in Foods

    1. What are examples of products or product categories that contain 
sesame as a spice, flavor, color, or incidental additive and that do 
not list ``sesame'' on the product labeling?
    2. What amount or concentration of sesame is in products or product 
categories that contain sesame as a spice, flavor, color, or incidental 
additive and that do not list ``sesame'' on the product labeling? 
Please provide a unit of measure (e.g., ``5 grams of sesame per 
kilogram of packaged food product'' or ``50 milligrams of sesame 
protein per serving'').
    3. What are examples of products or product categories other than 
``spices'' that contain sesame in one of the listed ingredients, but 
the common or usual name of that ingredient does not list ``sesame,'' 
specifically, on the product labeling? Please provide a copy of the 
labeling, if available.
    4. What amount or concentration of sesame is in products or product 
categories that contain sesame in one of the listed ingredients, but 
the common or usual name of that ingredient does not list ``sesame,'' 
specifically, on the product labeling? Please provide a unit of measure 
(e.g., ``5 grams of sesame per kilogram of packaged food product'' or 
``50 milligrams of sesame protein per serving'').
    5. What are examples of food products or product categories in 
which sesame has been found in a product because of cross-contact?
    6. What amount or concentration of sesame has been found in 
products or product categories that contain sesame because of cross-
contact? Please provide a unit of measure (e.g., ``5 grams of sesame 
per kilogram of packaged food product'' or ``50 milligrams of sesame 
protein per serving'').

C. Possible Costs of Any Future Regulatory Action FDA Might Take 
Regarding Sesame

    1. What would the costs be if we established disclosure 
requirements for sesame? We are interested in any costs, specifically 
those to manufacturers for labeling changes to reflect sesame as an 
ingredient, spice, flavor, color, or incidental additive.
    2. What would the costs be to manufacturers to control allergen 
cross-contact from sesame and what would the costs be of educating food 
managers at retail or food establishments to control for sesame as an 
allergen?
    3. What steps have manufacturers taken to eliminate or reduce 
cross-contact from sesame and/or sesame-containing ingredients?

III. References

    The following references are on display at the Dockets Management 
Staff (see ADDRESSES) and are available for viewing by interested 
persons between 9 a.m. and 4 p.m., Monday through Friday; they are also 
available electronically at https://www.regulations.gov. FDA has 
verified the website addresses, as of the date this document publishes 
in the Federal Register, but websites are subject to change over time.

1. FDA. ``Food Allergies: What You Need to Know.'' March 2017. 
Available at https://www.fda.gov/downloads/Food/ResourcesForYou/Consumers/UCM220117.pdf.
2. ``Guidance for Industry: Questions and Answers Regarding Food 
Allergens, Including the Food Allergen Labeling and Consumer 
Protection Act of 2004'' (Edition 4). October 2006. Available at 
https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm059116.htm.
3. ``Guidance for Industry: Food Allergen Labeling Exemption 
Petitions and Notifications.'' May 2014. Available at https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm395494.htm.
4. Docket No. FDA-2014-P-2035, available at https://www.regulations.gov/docket?D=FDA-2014-P-2035.
5. ``Compliance Policy Guide Sec. 555.250 Statement of Policy for 
Labeling and Preventing Cross-contact of Common Food Allergens.'' 
August 2000. Available at https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-ice/documents/webcontent/ucm074552.pdf.

    Dated: October 24, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-23635 Filed 10-29-18; 8:45 am]
 BILLING CODE 4164-01-P



                                               54594                        Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices

                                               Staff. If you do not wish your name and                 physical sign, or other measure, that                 DEPARTMENT OF HEALTH AND
                                               contact information to be made publicly                 does not directly measure clinical                    HUMAN SERVICES
                                               available, you can provide this                         benefit but (1) is known to predict
                                               information on the cover sheet and not                  clinical benefit and can potentially be               Food and Drug Administration
                                               in the body of your comments and you                    used to support traditional approval of               [Docket No. FDA–2018–N–3809]
                                               must identify this information as                       a drug or biological product or (2) is
                                               ‘‘confidential.’’ Any information marked                reasonably likely to predict clinical                 Sesame as an Allergen in Foods
                                               as ‘‘confidential’’ will not be disclosed               benefit and could be used to support
                                               except in accordance with 21 CFR 10.20                                                                        AGENCY:    Food and Drug Administration,
                                                                                                       accelerated approval in accordance with               HHS.
                                               and other applicable disclosure law. For                section 506(c) of the FD&C Act (21
                                               more information about FDA’s posting                                                                          ACTION:   Notice; request for comments.
                                                                                                       U.S.C. 356(c)).
                                               of comments to public dockets, see 80                                                                         SUMMARY:    The Food and Drug
                                               FR 56469, September 18, 2015, or access                    This SE table includes SEs that
                                                                                                       sponsors have used as primary efficacy                Administration (FDA or we) invites data
                                               the information at: https://www.gpo.gov/                                                                      and other information on the prevalence
                                               fdsys/pkg/FR-2015-09-18/pdf/2015-                       clinical trial endpoints for approval of
                                                                                                                                                             and severity of sesame allergies in the
                                               23389.pdf.                                              new drug applications (NDAs) or
                                                                                                                                                             United States and the prevalence of
                                                  Docket: For access to the docket to                  biologics license applications (BLAs).                sesame-containing foods sold in the
                                               read background documents or the                        The table also includes SEs that may be               United States that are not required to
                                               electronic and written/paper comments                   appropriate for use as a primary efficacy             disclose sesame as an ingredient. We are
                                               received, go to https://                                clinical trial endpoint for drug or                   taking this action to inform possible
                                               www.regulations.gov and insert the                      biologic approval, although the SEs                   regulatory action on sesame to protect
                                               docket number, found in brackets in the                 have not necessarily been used to                     and promote the public health.
                                               heading of this document, into the                      support an approved NDA or BLA. FDA                   DATES: Submit either electronic or
                                               ‘‘Search’’ box and follow the prompts                   believes that this table should facilitate            written comments on this document by
                                               and/or go to the Dockets Management                     discussions of potential SEs by sponsors              December 31, 2018.
                                               Staff, 5630 Fishers Lane, Rm. 1061,                     when developers are designing their                   ADDRESSES: You may submit comments
                                               Rockville, MD 20852.                                    drug development programs.                            as follows. Electronic comments must
                                               FOR FURTHER INFORMATION CONTACT:
                                                                                                       II. Additional Issues for Consideration               be submitted on or before December 31,
                                               Christopher Leptak, Center for Drug                                                                           2018. The https://www.regulations.gov
                                               Evaluation and Research, Food and                          To help FDA determine the utility of               electronic filing system will accept
                                               Drug Administration, 10903 New                                                                                comments until 11:59 p.m. Eastern Time
                                                                                                       the SE table, develop future iterations of
                                               Hampshire Ave., Bldg. 22, Rm. 6461,                                                                           at the end of December 31, 2018.
                                                                                                       the SE table, and identify best methods
                                               Silver Spring, MD 20993–0002, 301–                                                                            Comments received by mail/hand
                                                                                                       for conveying this information on FDA’s
                                               796–0017, Christopher.Leptak@                                                                                 delivery/courier (for written/paper
                                               fda.hhs.gov; or Stephen Ripley, Center                  website, FDA is soliciting public
                                                                                                       suggestions and comments on the SE                    submissions) will be considered timely
                                               for Biologics Evaluation and Research,                                                                        if they are postmarked or the delivery
                                               Food and Drug Administration, 10903                     table listed on the following web page:
                                                                                                       https://www.fda.gov/Drugs/                            service acceptance receipt is on or
                                               New Hampshire Ave., Bldg. 71, Rm.                                                                             before that date.
                                               7301, Silver Spring, MD 20993–0002,                     DevelopmentApprovalProcess/
                                               240–402–7911.                                           DevelopmentResources/ucm60                            Electronic Submissions
                                               SUPPLEMENTARY INFORMATION:                              6684.htm.                                               Submit electronic comments in the
                                                                                                          Specifically, FDA welcomes                         following way:
                                               I. Background                                                                                                   • Federal eRulemaking Portal:
                                                                                                       comments concerning: (1) The utility of
                                                  Section 3011 of the 21st Century                     the SE table; (2) suggestions on SEs that             https://www.regulations.gov. Follow the
                                               Cures Act established section 507 of the                may not be reflected on the current SE                instructions for submitting comments.
                                               Federal Food, Drug, and Cosmetic Act                    table but that have been used for drug                Comments submitted electronically,
                                               (FD&C Act) (21 U.S.C. 357), which                       or biologic approvals; (3) the best                   including attachments, to https://
                                               mandates that FDA publish a list of                     approach for developing future                        www.regulations.gov will be posted to
                                               surrogate endpoints used as a basis to                  iterations of the table, and (4) SE table             the docket unchanged. Because your
                                               approve or license a drug or biological                 questions you would like FDA to                       comment will be made public, you are
                                               product under both accelerated and                      address in future communications. As                  solely responsible for ensuring that your
                                               traditional approval provisions. The SE                                                                       comment does not include any
                                                                                                       required by section 507(c)(1) of the
                                               table fulfills this legislative requirement                                                                   confidential information that you or a
                                                                                                       FD&C Act, FDA will update this table
                                               and is intended to provide valuable                                                                           third party may not wish to be posted,
                                               information for drug developers on                      on the website every 6 months. The
                                                                                                                                                             such as medical information, your or
                                               endpoints that may be considered and                    Agency will consider comments
                                                                                                                                                             anyone else’s Social Security number, or
                                               discussed with FDA for individual                       submitted to the docket as it revises the             confidential business information, such
                                               development programs. FDA refers the                    SE table.                                             as a manufacturing process. Please note
                                               public to the following web page for                      Dated: October 25, 2018.                            that if you include your name, contact
                                               additional background information as                    Leslie Kux,                                           information, or other information that
                                               well as the SE table: https://
khammond on DSK30JT082PROD with NOTICES




                                                                                                       Associate Commissioner for Policy.                    identifies you in the body of your
                                               www.fda.gov/Drugs/Development                                                                                 comments, that information will be
                                                                                                       [FR Doc. 2018–23641 Filed 10–29–18; 8:45 am]
                                               ApprovalProcess/Development                                                                                   posted on https://www.regulations.gov.
                                               Resources/ucm606684.htm.                                BILLING CODE 4164–01–P                                  • If you want to submit a comment
                                                  Section 507(e)(9) of the FD&C Act                                                                          with confidential information that you
                                               defines the term ‘‘surrogate endpoint’’ to                                                                    do not wish to be made available to the
                                               mean a marker, e.g., a laboratory                                                                             public, submit the comment as a
                                               measurement, radiographic image,                                                                              written/paper submission and in the


                                          VerDate Sep<11>2014   17:34 Oct 29, 2018   Jkt 247001   PO 00000   Frm 00029   Fmt 4703   Sfmt 4703   E:\FR\FM\30OCN1.SGM   30OCN1


                                                                            Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices                                           54595

                                               manner detailed (see ‘‘Written/Paper                    electronic and written/paper comments                 allergic reactions. We issued guidance
                                               Submissions’’ and ‘‘Instructions’’).                    received, go to https://                              in 2006 to help the public understand
                                                                                                       www.regulations.gov and insert the                    our implementation of the amendments,
                                               Written/Paper Submissions
                                                                                                       docket number, found in brackets in the               including what foods and manufacturers
                                                  Submit written/paper submissions as                  heading of this document, into the                    are subject to the amendments and
                                               follows:                                                ‘‘Search’’ box and follow the prompts                 labeling requirements (Ref. 2). We
                                                  • Mail/Hand delivery/Courier (for                    and/or go to the Dockets Management                   issued another guidance in 2014 to
                                               written/paper submissions): Dockets                     Staff, 5630 Fishers Lane, Rm. 1061,                   clarify the information we need when
                                               Management Staff (HFA–305), Food and                    Rockville, MD 20852.                                  considering whether to exempt certain
                                               Drug Administration, 5630 Fishers                                                                             ingredients derived from major food
                                                                                                       FOR FURTHER INFORMATION CONTACT:
                                               Lane, Rm. 1061, Rockville, MD 20852.                                                                          allergens from the allergen labeling
                                                  • For written/paper comments                         Carol D’Lima, Office of Nutrition and
                                                                                                       Food Labeling, Center for Food Safety                 requirements (Ref. 3). These statutory
                                               submitted to the Dockets Management                                                                           requirements with respect to a label or
                                               Staff, FDA will post your comment, as                   and Applied Nutrition, Food and Drug
                                                                                                       Administration, 5001 Campus Dr.,                      labeling for major food allergens do not
                                               well as any attachments, except for                                                                           alter the authority of the Secretary of
                                               information submitted, marked and                       College Park, MD 20740, 240–402–2033.
                                                                                                                                                             Health and Human Services under the
                                               identified, as confidential, if submitted               SUPPLEMENTARY INFORMATION:
                                                                                                                                                             FD&C Act to require a label or labeling
                                               as detailed in ‘‘Instructions.’’                        I. Background                                         for other food allergens (21 U.S.C. 343
                                                  Instructions: All submissions received                                                                     note).
                                               must include the Docket No. FDA–                           Food allergies occur when the body’s
                                                                                                                                                                A common or usual name must
                                               2018–N–3809 for ‘‘Sesame as an                          immune system reacts to certain food
                                                                                                                                                             accurately identify or describe, in as
                                               Allergen in Foods.’’                                    proteins (Ref. 1). Allergic reactions to              simple and direct terms as possible, the
                                                  Received comments, those filed in a                  food due to immunoglobulin E (IgE)                    basic nature of the food or its
                                               timely manner (see ADDRESSES), will be                  antibodies cause the body to release                  characterizing properties or ingredients
                                               placed in the docket and, except for                    inflammatory chemicals and can be                     and can either be the name established
                                               those submitted as ‘‘Confidential                       particularly severe, leading to symptoms              by common use or the name required by
                                               Submissions,’’ publicly viewable at                     such as hives, facial swelling, vomiting,             a regulation (21 CFR 102.5). In addition
                                               https://www.regulations.gov or at the                   wheezing, shock, and even death.                      to the specific requirement for allergen
                                               Dockets Management Staff between 9                      Because there is no cure for food                     labeling, any food is misbranded unless
                                               a.m. and 4 p.m., Monday through                         allergies, allergic consumers must use                its label uses: (1) The common or usual
                                               Friday.                                                 avoidance to prevent allergic reactions.              name of the food, if it has one, and (2)
                                                  • Confidential Submissions—To                        Successful avoidance requires, among                  the common or usual name of each
                                               submit a comment with confidential                      other things, that allergic consumers                 ingredient, if the food is made from two
                                               information that you do not wish to be                  and their caregivers can read and                     or more ingredients (section 403(i) of
                                               made publicly available, submit your                    understand the relevant information on                the FD&C Act). Thus, the FD&C Act
                                               comments only as a written/paper                        packaged food labels and can identify                 includes other authorities that assist
                                               submission. You should submit two                       food allergens in other settings, such as             consumers with a food allergy or other
                                               copies total. One copy will include the                 at retail or food service establishments.             reason for avoiding an ingredient. For
                                               information you claim to be confidential                   The Federal Food, Drug, and Cosmetic               example, the label of a food made with
                                               with a heading or cover note that states                Act (FD&C Act) requires that a food                   sugar must declare this ingredient by its
                                               ‘‘THIS DOCUMENT CONTAINS                                (other than a raw agricultural                        common or usual name—‘‘sugar’’—
                                               CONFIDENTIAL INFORMATION.’’ We                          commodity) that bears or contains a                   rather than the chemical name
                                               will review this copy, including the                    ‘‘major food allergen’’ declare the                   ‘‘sucrose’’ (see section 403(i) of the
                                               claimed confidential information, in our                allergen using its ‘‘common or usual                  FD&C Act (21 U.S.C. 343(i))).
                                               consideration of comments. The second                   name.’’ A food is misbranded if it                       In addition, section 403(x) of the
                                               copy, which will have the claimed                       contains a major food allergen and fails              FD&C Act gives us the authority to issue
                                               confidential information redacted/                      to declare that major food allergen on its            regulations requiring the disclosure of
                                               blacked out, will be available for public               label using the major food allergen’s                 spices, flavorings, colorings, and
                                               viewing and posted on https://                          common or usual name (section 403(w)                  incidental additives that are, or contain,
                                               www.regulations.gov. Submit both                        of the FD&C Act). The FD&C Act defines                allergens other than the eight major food
                                               copies to the Dockets Management Staff.                 a ‘‘major food allergen,’’ in part, as any            allergens. We relied on this authority, in
                                               If you do not wish your name and                        of the following:                                     part, to require the labeling of carmine
                                               contact information to be made publicly                    • Milk,                                            and cochineal in foods (see 74 FR 207).
                                               available, you can provide this                            • Eggs,                                               In 2014, the Center for Science in the
                                               information on the cover sheet and not                     • Fish (e.g., bass, flounder, or cod),             Public Interest, several medical
                                               in the body of your comments and you                       • Crustacean shellfish (e.g., crab,                professionals, and two consumer
                                               must identify this information as                       lobster, or shrimp),                                  advocacy groups submitted a citizen
                                               ‘‘confidential.’’ Any information marked                   • Tree nuts (e.g., almonds, pecans, or             petition (Ref. 4) requesting, in part, that
                                               as ‘‘confidential’’ will not be disclosed               walnuts),                                             we issue a rule to require that sesame
                                               except in accordance with 21 CFR 10.20                     • Wheat,                                           seeds and sesame products be regulated
                                               and other applicable disclosure law. For                   • Peanuts, and                                     in a manner similar to the manner in
                                                                                                          • Soybeans.                                        which major food allergens are
khammond on DSK30JT082PROD with NOTICES




                                               more information about FDA’s posting
                                               of comments to public dockets, see 80                      See section 201(qq)(1) of the FD&C                 regulated under the FD&C Act, and
                                               FR 56469, September 18, 2015, or access                 Act (21 U.S.C. 321(qq)(1)). When                      specifically to require sesame’s
                                               the information at: https://www.gpo.gov/                Congress amended the FD&C Act                         disclosure by the common or usual
                                               fdsys/pkg/FR-2015-09-18/pdf/2015-                       regarding food allergens in 2004, these               name ‘‘sesame’’ in food labeling. The
                                               23389.pdf.                                              eight foods and food groups, out of more              petition noted, among other things, that
                                                  Docket: For access to the docket to                  than 160 identified food allergens,                   the European Union, Canada, Australia,
                                               read background documents or the                        accounted for 90 percent of serious food              and New Zealand require labeling of


                                          VerDate Sep<11>2014   17:34 Oct 29, 2018   Jkt 247001   PO 00000   Frm 00030   Fmt 4703   Sfmt 4703   E:\FR\FM\30OCN1.SGM   30OCN1


                                               54596                        Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices

                                               sesame and provided scientific                          homes, childcare centers, and temporary               sesame? We are interested in any costs,
                                               information to support the petitioners’                 food establishments)?                                 specifically those to manufacturers for
                                               argument that sesame is an allergen of                     5. In packaged food products, what                 labeling changes to reflect sesame as an
                                               public health concern. The petition also                proportion of allergic reactions to                   ingredient, spice, flavor, color, or
                                               requested that we add sesame to our list                sesame is due to:                                     incidental additive.
                                               of allergens in our Compliance Policy                      a. Sesame in generically listed spices,               2. What would the costs be to
                                               Guide, which includes discussion of                     flavorings, colorings, or incidental                  manufacturers to control allergen cross-
                                               adulteration due to insufficient controls               additives;                                            contact from sesame and what would
                                               to prevent potential allergen cross-                       b. Sesame used as an ingredient and                the costs be of educating food managers
                                               contact (the unintentional incorporation                listed by some other name (e.g., ‘‘tahini’’           at retail or food establishments to
                                               of allergens into foods that are not                    rather than ‘‘sesame’’); or                           control for sesame as an allergen?
                                               intended to include those allergens)                       c. Cross-contact?
                                               (Ref. 5). Since the citizen petition was                                                                        3. What steps have manufacturers
                                                                                                       B. Prevalence and Amounts of                          taken to eliminate or reduce cross-
                                               posted, more than 750 comments have
                                                                                                       Undeclared Sesame in Foods                            contact from sesame and/or sesame-
                                               been submitted to the docket.
                                                                                                          1. What are examples of products or                containing ingredients?
                                                  We are interested in learning more
                                               about the prevalence and severity of                    product categories that contain sesame                III. References
                                               sesame allergies in the United States,                  as a spice, flavor, color, or incidental
                                               and the prevalence of sesame-containing                 additive and that do not list ‘‘sesame’’                The following references are on
                                               foods sold in the United States that are                on the product labeling?                              display at the Dockets Management Staff
                                               not required to disclose sesame as an                      2. What amount or concentration of                 (see ADDRESSES) and are available for
                                               ingredient. We will consider the data                   sesame is in products or product                      viewing by interested persons between
                                               and other information submitted, along                  categories that contain sesame as a                   9 a.m. and 4 p.m., Monday through
                                               with previously submitted information,                  spice, flavor, color, or incidental                   Friday; they are also available
                                               to inform possible steps on sesame as an                additive and that do not list ‘‘sesame’’              electronically at https://
                                               allergen in food to protect and promote                 on the product labeling? Please provide               www.regulations.gov. FDA has verified
                                               the public health.                                      a unit of measure (e.g., ‘‘5 grams of                 the website addresses, as of the date this
                                                                                                       sesame per kilogram of packaged food                  document publishes in the Federal
                                               II. Additional Issues for Consideration;                product’’ or ‘‘50 milligrams of sesame                Register, but websites are subject to
                                               Request for Data and Information                        protein per serving’’).                               change over time.
                                                 We invite comment, particularly                          3. What are examples of products or
                                                                                                                                                             1. FDA. ‘‘Food Allergies: What You Need to
                                               scientific data and other evidence, about               product categories other than ‘‘spices’’
                                                                                                                                                                   Know.’’ March 2017. Available at https://
                                               the following topics:                                   that contain sesame in one of the listed
                                                                                                                                                                   www.fda.gov/downloads/Food/
                                                                                                       ingredients, but the common or usual
                                               A. Prevalence of Allergies and Allergic                                                                             ResourcesForYou/Consumers/UCM22
                                                                                                       name of that ingredient does not list
                                               Reactions Due to Sesame in the United                                                                               0117.pdf.
                                                                                                       ‘‘sesame,’’ specifically, on the product
                                               States                                                                                                        2. ‘‘Guidance for Industry: Questions and
                                                                                                       labeling? Please provide a copy of the
                                                                                                                                                                   Answers Regarding Food Allergens,
                                                  1. What is the prevalence of IgE-                    labeling, if available.
                                                                                                                                                                   Including the Food Allergen Labeling
                                               mediated sesame food allergies in the                      4. What amount or concentration of                       and Consumer Protection Act of 2004’’
                                               United States? Please provide any                       sesame is in products or product                            (Edition 4). October 2006. Available at
                                               studies or data that support your                       categories that contain sesame in one of                    https://www.fda.gov/Food/
                                               conclusion, and provide your unit of                    the listed ingredients, but the common                      GuidanceRegulation/Guidance
                                               measure (e.g., ‘‘1 in 10,000 adults’’).                 or usual name of that ingredient does                       DocumentsRegulatoryInformation/
                                               What is the nature of the allergic                      not list ‘‘sesame,’’ specifically, on the                   ucm059116.htm.
                                               response(s) to sesame in food and what                  product labeling? Please provide a unit               3. ‘‘Guidance for Industry: Food Allergen
                                               are the impacts on consumers?                           of measure (e.g., ‘‘5 grams of sesame per                   Labeling Exemption Petitions and
                                                                                                       kilogram of packaged food product’’ or                      Notifications.’’ May 2014. Available at
                                                  2. How does the prevalence of IgE-                   ‘‘50 milligrams of sesame protein per
                                               mediated sesame food allergies in the                                                                               https://www.fda.gov/Food/
                                                                                                       serving’’).                                                 GuidanceRegulation/Guidance
                                               United States compare to the prevalence                    5. What are examples of food products
                                               of IgE-mediated allergies to the major                                                                              DocumentsRegulatoryInformation/
                                                                                                       or product categories in which sesame                       ucm395494.htm.
                                               food allergens? Please provide any                      has been found in a product because of                4. Docket No. FDA–2014–P–2035, available
                                               studies or data that support your                       cross-contact?                                              at https://www.regulations.gov/
                                               conclusion.                                                6. What amount or concentration of                       docket?D=FDA-2014-P-2035.
                                                  3. What proportion of allergic                       sesame has been found in products or                  5. ‘‘Compliance Policy Guide Sec. 555.250
                                               reactions in the United States may be                   product categories that contain sesame                      Statement of Policy for Labeling and
                                               attributed specifically to exposure to                  because of cross-contact? Please provide                    Preventing Cross-contact of Common
                                               undeclared sesame? Please provide any                   a unit of measure (e.g., ‘‘5 grams of                       Food Allergens.’’ August 2000. Available
                                               studies or data that support your                       sesame per kilogram of packaged food                        at https://www.fda.gov/ucm/groups/
                                               conclusion.                                             product’’ or ‘‘50 milligrams of sesame                      fdagov-public/@fdagov-afda-ice/
khammond on DSK30JT082PROD with NOTICES




                                                  4. What proportion of allergic                       protein per serving’’).                                     documents/webcontent/ucm074552.pdf.
                                               reactions to undeclared sesame occur in                                                                         Dated: October 24, 2018.
                                               response to sesame found in packaged                    C. Possible Costs of Any Future
                                               food products versus sesame found in                    Regulatory Action FDA Might Take                      Leslie Kux,
                                               foods served at retail or food service                  Regarding Sesame                                      Associate Commissioner for Policy.
                                               establishments (e.g., restaurants, grocery                1. What would the costs be if we                    [FR Doc. 2018–23635 Filed 10–29–18; 8:45 am]
                                               stores, supermarkets, hospitals, nursing                established disclosure requirements for               BILLING CODE 4164–01–P




                                          VerDate Sep<11>2014   17:34 Oct 29, 2018   Jkt 247001   PO 00000   Frm 00031   Fmt 4703   Sfmt 4703   E:\FR\FM\30OCN1.SGM   30OCN1



Document Created: 2018-10-30 00:43:38
Document Modified: 2018-10-30 00:43:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; request for comments.
DatesSubmit either electronic or written comments on this document by December 31, 2018.
ContactCarol D'Lima, Office of Nutrition and Food Labeling, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402- 2033.
FR Citation83 FR 54594 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR